Answer
It is licensed for selected locally advanced or metastatic non-small cell lung cancers: activating EGFR mutation-positive disease in EGFR-inhibitor-naive adults and squamous disease progressing during or after platinum chemotherapy.
Sources for this answer
- Giotrif 20 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.